News & Events
Crinetics Pharmaceuticals Appoints Marc Wilson as Chief Financial Officer
SAN DIEGO – January 4, 2018 – Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and...
READ MORECrinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
SAN DIEGO – January 2, 2018 – Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and...
READ MORECrinetics CEO Talks with Pituitary World News About the Importance of Patient Advocacy in Developing New Medicines
Our founder and CEO, Scott Struthers, Ph.D., spoke with J D Faccinetti for a podcast for Pituitary World News, looking...
READ MORECrinetics Pharmaceuticals Initiates Phase 1 Study of Lead Candidate CRN00808 for Acromegaly
SAN DIEGO – October 26, 2017 – Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and...
READ MORECrinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s Disease
SAN DIEGO – September 6, 2017 – Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and...
READ MORECrinetics Pharmaceuticals Awarded $2.8 Million SBIR Grant to Support Development of Acromegaly Drug Candidate CRN00808
SAN DIEGO – July 13, 2017 – Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and...
READ MORECrinetics Pharmaceuticals Appoints Anne Klibanski, M.D. to Scientific Advisory Board
SAN DIEGO – November 10, 2016 – Crinetics Pharmaceuticals (“Crinetics”), an innovative therapeutics company focused on specialty endocrine disorders and...
READ MORECrinetics Pharmaceuticals Appoints Ajay Madan as Vice President, Development
SAN DIEGO – June 6, 2016 – Crinetics Pharmaceuticals (“Crinetics”), an innovative therapeutics company focused on specialty endocrine disorders, announced...
READ MOREThe San Diego Union-Tribune: Crinetics raises $40 Million
November 2, 2015 — Seeking to get its first drug ready for human testing, San Diego biotech Crinetics Pharmaceuticals has...
READ MOREXconomy: Crinetics Pharma Raises $40M in Comeback for Ex-Neurocrine Bio Team
November 2, 2015 — After spending the past six years scavenging for lab equipment and operating on a shoestring, San...
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
